441 related articles for article (PubMed ID: 38259314)
1. Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction.
Jalink EA; Schonk AW; Boon RA; Juni RP
Front Cardiovasc Med; 2023; 10():1300375. PubMed ID: 38259314
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in mechanistic studies of heart failure with preserved ejection fraction and its comorbidities-Role of microRNAs.
Li X; Sun M; Wang Z; Sun S; Wang Y
Eur J Clin Invest; 2024 Mar; 54(3):e14130. PubMed ID: 38071416
[TBL] [Abstract][Full Text] [Related]
3. Endothelial Dysfunction in Heart Failure With Preserved Ejection Fraction: What are the Experimental Proofs?
Cornuault L; Rouault P; Duplàa C; Couffinhal T; Renault MA
Front Physiol; 2022; 13():906272. PubMed ID: 35874523
[TBL] [Abstract][Full Text] [Related]
4. Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies.
Hamdani N; Costantino S; Mügge A; Lebeche D; Tschöpe C; Thum T; Paneni F
Eur Heart J; 2021 May; 42(20):1940-1958. PubMed ID: 36282124
[TBL] [Abstract][Full Text] [Related]
5. Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies.
Hamdani N; Costantino S; Mügge A; Lebeche D; Tschöpe C; Thum T; Paneni F
Eur Heart J; 2021 May; 42(20):1940-1958. PubMed ID: 33948637
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide screening for circRNAs in epicardial adipose tissue of heart failure patients with preserved ejection fraction.
He S; Zhu H; Zhang J; Yang X; Zhao L
Am J Transl Res; 2023; 15(7):4610-4619. PubMed ID: 37560213
[TBL] [Abstract][Full Text] [Related]
7. Non-coding RNAs: targets for Chinese herbal medicine in treating myocardial fibrosis.
Wang M; Yan M; Tan L; Zhao X; Liu G; Zhang Z; Zhang J; Gao H; Qin W
Front Pharmacol; 2024; 15():1337623. PubMed ID: 38476331
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases.
Singh DD; Kim Y; Choi SA; Han I; Yadav DK
Cells; 2023 Jun; 12(12):. PubMed ID: 37371099
[TBL] [Abstract][Full Text] [Related]
9. Heart Failure with Preserved Ejection Fraction: the Major Unmet Need in Cardiology.
Shim CY
Korean Circ J; 2020 Dec; 50(12):1051-1061. PubMed ID: 33150751
[TBL] [Abstract][Full Text] [Related]
10. A transcriptomic profile of topping responsive non-coding RNAs in tobacco roots (Nicotiana tabacum).
Chen X; Sun S; Liu F; Shen E; Liu L; Ye C; Xiao B; Timko MP; Zhu QH; Fan L; Cao P
BMC Genomics; 2019 Nov; 20(1):856. PubMed ID: 31726968
[TBL] [Abstract][Full Text] [Related]
11. Understanding heart failure with preserved ejection fraction: where are we today?
van Heerebeek L; Paulus WJ
Neth Heart J; 2016 Apr; 24(4):227-36. PubMed ID: 26909795
[TBL] [Abstract][Full Text] [Related]
12. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
[TBL] [Abstract][Full Text] [Related]
13. Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis.
Bilak JM; Alam U; Miller CA; McCann GP; Arnold JR; Kanagala P
Card Fail Rev; 2022 Jan; 8():e24. PubMed ID: 35846985
[TBL] [Abstract][Full Text] [Related]
14. Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction.
Altara R; Giordano M; Nordén ES; Cataliotti A; Kurdi M; Bajestani SN; Booz GW
Front Endocrinol (Lausanne); 2017; 8():160. PubMed ID: 28769873
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of circulating non-coding RNAs in metabolic diseases: Emphasis on obesity, diabetes, cardiovascular diseases and metabolic syndrome.
Dandare A; Khan MJ; Naeem A; Liaquat A
Genes Dis; 2023 Nov; 10(6):2393-2413. PubMed ID: 37554181
[TBL] [Abstract][Full Text] [Related]
16. Age and Sex Differences in Heart Failure With Preserved Ejection Fraction.
Kobak KA; Zarzycka W; Chiao YA
Front Aging; 2022; 3():811436. PubMed ID: 35821846
[TBL] [Abstract][Full Text] [Related]
17. Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic Cardiomyopathy.
Rai AK; Lee B; Gomez R; Rajendran D; Khan M; Garikipati VNS
Front Physiol; 2020; 11():612722. PubMed ID: 33551838
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a robust mouse model of heart failure with preserved ejection fraction.
Matsiukevich D; Kovacs A; Li T; Kokkonen-Simon K; Matkovich SJ; Oladipupo SS; Ornitz DM
Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H203-H231. PubMed ID: 37204871
[TBL] [Abstract][Full Text] [Related]
19. The Molecular and Cellular Mechanisms Associated with a Microvascular Inflammation in the Pathogenesis of Heart Failure with Preserved Ejection Fraction.
Ovchinnikov AG; Arefieva TI; Potekhina AV; Filatova AY; Ageev FT; Boytsov SA
Acta Naturae; 2020; 12(2):40-51. PubMed ID: 32742726
[TBL] [Abstract][Full Text] [Related]
20. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
